BACKGROUND: @entity3981 ( @entity3981 ) of the pancreas is characterized by better long-term survival compared with the more common @entity420 , and prognosis is better in resected compared with nonresected @entity1 . The aim of the present study was to investigate the role of surgery in @entity3981 with limited @entity3 . METHODS: All @entity1 with histologically confirmed @entity3981 treated at the investigators' institution between October 2001 and September 2009 were identified from a prospective database. Clinicopathologic details, perioperative results, and follow-up results were analyzed. RESULTS: Seventeen @entity1 with nonmetastatic and metastatic @entity3981 were identified. Initially, localized, locoregional, and @entity3 was present in 5, 7, and 5 @entity1 , respectively. Pancreatic resections were performed in 15 @entity1 . In limited @entity3 , additional liver resection was performed in 3 @entity1 and omentectomy in 1 @entity1 . In 2 @entity1 , metachronous liver metastases were resected. With a median follow-up period of 36.5 months, overall 1-year, 2-year, and 3-year survival rates were 88%, 65%, and 47%, respectively. Survival of resected @entity1 with metastatic and nonmetastatic disease showed no differences between the 2 groups. CONCLUSIONS: @entity3981 of the pancreas is a relatively rare @entity5 entity for which resection may result in long-term survival even in limited @entity3 .

@entity3981 : is resection justified even in limited XXXX ?

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity3981 :: ('MESH:D018267', 'Disease') :: ['ACC', 'Acinar cell carcinoma'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastatic disease'] @entity420 :: ('MESH:D000230', 'Disease') :: ['ductal adenocarcinoma']
@entity3 :: (MESH:D009362,Disease) :: ['metastatic disease']
